Literature DB >> 14160508

TETRACYCLINE TOXICITY IN PREGNANCY. LIVER AND PANCREATIC DYSFUNCTION.

P J WHALLEY, R H ADAMS, B COMBES.   

Abstract

Entities:  

Keywords:  CHLORAMPHENICOL; ENZYME TESTS; ESCHERICHIA COLI INFECTIONS; JAUNDICE; JAUNDICE, OBSTRUCTIVE; LIVER DISEASES; LIVER FUNCTION TESTS; PANCREAS; PANCREATITIS; PREGNANCY; PREGNANCY COMPLICATIONS; PYELONEPHRITIS; STREPTOMYCIN; TETRACYCLINE; TOXICOLOGIC REPORT; UREMIA

Mesh：

Substances：

Year:  1964        PMID： 14160508

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  27 in total

1.  Fatty liver: biochemical and clinical considerations.

Authors:  A M Hoyumpa; H L Greene; G D Dunn; S Schenker
Journal:  Am J Dig Dis       Date:  1975-12

2.  TETRACYCLINE HEPATOTOXICITY.

Authors: 
Journal:  Br Med J       Date:  1964-12-19

3.  METABOLIC EFFECTS OF THE STEROID ANTIBIOTIC FUSIDIC ACID.

Authors:  V WYNN
Journal:  Br Med J       Date:  1965-05-29

Review 4.  The safety of antimalarial drugs in pregnancy.

Authors:  P A Phillips-Howard; D Wood
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

5.  Tetracyclines in renal insufficiency: resolution of a therapeutic dilemma.

Authors:  A Whelton
Journal:  Bull N Y Acad Med       Date:  1978-02

6.  Effects of oxytetracycline on the rat exocrine pancreas.

Authors:  C Lorenzo; M L del Olmo Martinez; L Pastor; A Almaraz; A Belmonte; A Caro-Patón
Journal:  Int J Pancreatol       Date:  1999-12

7.  Use and safety of antimicrobial agents during pregnancy.

Authors:  A W Chow; P J Jewesson
Journal:  West J Med       Date:  1987-06

Review 8.  Systemic agents in the management of acne.

Authors:  R M Reisner
Journal:  Calif Med       Date:  1967-01

9.  The effect of tetracycline on human liver cells in culture.

Authors:  A J Zuckerman; S F Baker; L J Dunkley
Journal:  Br J Exp Pathol       Date:  1968-02

Review 10.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.